Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx - Related Studies

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

This study is ongoing, but not recruiting participants.

Study NCT00004164. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Nasopharyngeal Neoplasms

3	More general conditions related to this trial
		Nasopharyngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		cisplatin
		docetaxel
		filgrastim
		fluorouracil
		leucovorin calcium
		radiation therapy

5	Additional drug interventions recognized in this trial
		Leucovorin

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		Dana-Farber Cancer Institute
		National Cancer Institute (NCI)